Omega-3 (EPA/DHA)
Cardiometabolic & inflammation-related outcomes; can support endurance recovery signals; evidence depends on dose & baseline intake.
Save how you reacted, what dose worked, what to watch for, or anything you want to remember later in your Notes tab.
Fishy aftertaste/burps — take with food or use enteric-coated softgels
Mild anticoagulant effect — caution pre-surgery or with blood thinners
Context: doses >3g EPA+DHA/day
High-dose omega-3 (≥2 g EPA+DHA/day) consistently reduces fasting triglycerides by 15–30% in adults with elevated baseline levels.
Omega-3 PUFA supplementation produced a statistically significant reduction in DOMS (MD −0.93, 95% CI −1.44 to −0.42; p=0.0004) across 12 RCTs, though the effect size fell below the minimal clinically important difference of 1.4 on a 10-point VAS. Low-quality evidence overall.
Omega-3 supplementation associated with reductions in cardiovascular events; benefit most consistent at higher EPA+DHA doses (≥2 g/day) & in high-risk populations.
Stacks containing Omega-3 (EPA/DHA)
Public community stacks that include this ingredient.
Your personalized stack
Built from your goals & the supplement evidence library. You can edit doses & timing.
Longevity & Metabolic Health Base
Foundational stack aimed at mitochondrial function, insulin sensitivity, & long-term healthspan.
Longevity & Heart Health Base
Targets cardiometabolic markers associated with long-term health.